Transform standard host strains into optimized chassis for efficient biosynthesis of biologics, materials, and specialty chemicals.
Specialized development of glycofactories with optimized sugar donor pools and glycosyltransferase expression for high-fidelity product output.
We combine precision genome editing with metabolic pathway reconstruction to create robust production strains tailored to your target product.
Our CRISPR-based platform enables concurrent modifications of multiple genetic loci, including targeted knockouts and site-specific integration of heterologous biosynthetic pathways.
Using dynamic flux analysis and rational design, we redirect cellular resources toward the target metabolite by eliminating competing pathways and optimizing precursor supply.
Choose the most suitable microbial or mammalian host based on desired post-translational modifications and application requirements.
Iterative rounds of genetic design, construction, and phenotypic screening to converge on a high-performance chassis.
Validation at genotype and phenotype levels, including growth kinetics, product titer, and off-target assessment.
Each project delivers a fully characterized engineered strain along with a comprehensive data report.
Each project is scoped individually based on your target product and host requirements. The table below outlines typical parameters.
| Parameter | Typical project scope |
|---|---|
| Host organism | E. coli, S. cerevisiae, P. pastoris, or other microbial/mammalian cells; custom host available upon request |
| Number of genetic modifications | As scoped per project; typical range 1–5 targeted loci |
| Editing type | Knockout is primary; knock-in and precise point mutations available case-by-case |
| Integration method | CRISPR-Cas9 or variant; site-specific recombinase when applicable |
| Strain screening approach | Colony PCR, restriction digest, or sequencing for genotype; growth curve and product titer for phenotype |
| Off-target analysis | In silico prediction plus targeted amplicon sequencing; whole-genome sequencing when scoped |
| Metabolic analysis | Targeted metabolite profiling or flux analysis based on project needs |
| Project deliverable format | Glycerol stock, sequenced plasmid, QC report |
A streamlined five-step process from initial discussion to final strain delivery.
We work with you to select the optimal host and design the metabolic modifications needed to achieve your target product. This includes identifying pathways to knock out or introduce.
Our team builds CRISPR vectors, repair templates, and any necessary donor constructs for the planned edits. All constructs are sequence-verified before use.
Transformation of the host with editing tools, followed by isolation of edited clones. We perform multi-locus editing when required, using optimized protocols for efficient modification.
Clones are genotyped by PCR/sequencing and phenotyped for growth kinetics and product titer. Metabolic flux analysis is applied if scoped to confirm desired pathway redirection.
We compile all experimental data, including QC results, into a project report including methods, QC, and datasets. The engineered strain and associated materials are delivered along with the documentation.
Our chassis development service supports a wide range of industries requiring stable, high-yield production strains.
Engineer microbial hosts to produce complex biologics such as glycosylated antibodies, cytokines, and enzymes with improved fidelity and yield.
Evaluate metabolic pathways for the production of fine chemicals, amino acids, vitamins, and other high-value compounds.
Develop chassis strains that convert renewable feedstocks into biodegradable polymers, building blocks for plastics.
Answers to typical concerns when planning a strain engineering project.
Each project includes host selection, design of genetic modifications, construction of editing tools, generation of engineered strains, screening and characterization (growth kinetics, product titer), and a final report with QC data. Physical deliverables include glycerol stocks, plasmids, and control strains.
We perform in silico off-target prediction using genome alignment tools, followed by targeted amplicon sequencing of predicted off-target sites. Whole-genome sequencing can be added if scoped to provide a comprehensive off-target profile.
Yes, we can accept customer-provided host strains subject to confidentiality and material transfer agreements. The final engineered strain and all generated materials remain your exclusive property.
Project duration depends on the number of targeted modifications, screening depth, and host organism. A timeline will be defined in the project proposal after consultation and is typically scoped to meet your deadline.
Get a customized quote for your Engineered microbial and Mammalian Hosts for High-Performance Production project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.